Sunesis Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report

Sunesis Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Sunesis Pharmaceuticals, Inc (Sunesis or 'the company') develops and commercializes oncology therapeutics for the treatment of hematologic and solid cancers. The company's major products include Vosaroxin, TAK-580, SSN-510 and Vecabrutinib. The company has collaboration agreement with Biogen Idec MA, Inc. to discover, develop and commercialize small molecule inhibitors of the human protein Raf kinase and with Takeda Pharmaceutical Company Limited to develop and commercialize preclinical inhibitors of PDK1 and TAK-580. Sunesis conducts various clinical trials and analysis for developing products that identifies and implements alternative methods for treating cancer and also obtain licenses for developing various critical products. The company is headquartered in South San Francisco, California, the US.

Scope

– Detailed information on Sunesis Pharmaceuticals, Inc. required for business and competitor intelligence needs

– A study of the major internal and external factors affecting Sunesis Pharmaceuticals, Inc. in the form of a SWOT analysis

– An in-depth view of the business model of Sunesis Pharmaceuticals, Inc. including a breakdown and examination of key business segments

– Intelligence on Sunesis Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

– News about Sunesis Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins

– Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Sunesis Pharmaceuticals, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Sunesis Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Sunesis Pharmaceuticals, Inc.'s business structure, strategy and prospects.

Table of Contents

Table of Contents

Company Snapshot

Sunesis Pharmaceuticals, Inc.: Company Overview

Sunesis Pharmaceuticals, Inc.: Overview and Key Facts

Sunesis Pharmaceuticals, Inc.: Overview

Sunesis Pharmaceuticals, Inc.: Key Facts

Sunesis Pharmaceuticals, Inc.: Key Employees

Sunesis Pharmaceuticals, Inc.: Key Employee Biographies

Sunesis Pharmaceuticals, Inc.: Major Products and Services

Sunesis Pharmaceuticals, Inc.: Company History

Sunesis Pharmaceuticals, Inc.: Management Statement

Sunesis Pharmaceuticals, Inc.: Locations and Subsidiaries

Sunesis Pharmaceuticals, Inc.: Key Competitors

Sunesis Pharmaceuticals, Inc.: Company Analysis

Sunesis Pharmaceuticals, Inc.: Business Description

Sunesis Pharmaceuticals, Inc.: SWOT Analysis

Sunesis Pharmaceuticals, Inc.: SWOT Overview

Sunesis Pharmaceuticals, Inc.: Strengths

Sunesis Pharmaceuticals, Inc.: Weaknesses

Sunesis Pharmaceuticals, Inc.: Opportunities

Sunesis Pharmaceuticals, Inc.: Threats

Sunesis Pharmaceuticals, Inc.: Corporate Financial Deals Activity

Sunesis Pharmaceuticals, Inc.: Financial Deals Overview

Sunesis Pharmaceuticals, Inc.: Targets and Partners

Sunesis Pharmaceuticals, Inc.: Top Deals 2016 - 2020YTD*

Sunesis Pharmaceuticals, Inc.: Advisors

Sunesis Pharmaceuticals, Inc.: Top Legal Advisors

Sunesis Pharmaceuticals, Inc.: Top Financial Advisors

Sunesis Pharmaceuticals, Inc.: Capital Raising

Sunesis Pharmaceuticals, Inc.: Partnership

Sunesis Pharmaceuticals, Inc.: Recent Developments

Sunesis Pharmaceuticals, Inc.: News and Events Summary

Sunesis Pharmaceuticals, Inc.: Corporate Governance

Sunesis Pharmaceuticals, Inc.: Financial Performance

Sunesis Pharmaceuticals, Inc.: Regulatory and Legal Events

Sunesis Pharmaceuticals, Inc.: Research & Development

Appendix

Contact Us

Methodology

About MarketLine

List of Tables

List of Tables

Table 1: Sunesis Pharmaceuticals, Inc.: Key Facts

Table 2: Sunesis Pharmaceuticals, Inc.: Key Employees

Table 3: Sunesis Pharmaceuticals, Inc.: Company History

Table 4: Sunesis Pharmaceuticals, Inc.: Locations and Subsidiaries

Table 5: Sunesis Pharmaceuticals, Inc.: Key Competitors

Table 6: Sunesis Pharmaceuticals, Inc.: Deal Activity by Deal Type – Volume (TTM*)

Table 7: Sunesis Pharmaceuticals, Inc.: Deal Activity by Deal Type – Volume (2016 – YTD*2020)

Table 8: Sunesis Pharmaceuticals, Inc.: Targets and Partners

Table 9: Sunesis Pharmaceuticals, Inc.: Top Deals 2016 – 2020YTD*

Table 10: Sunesis Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)

Table 11: Sunesis Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)

Table 12: Sunesis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2016 – YTD*2020)

Table 13: Sunesis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2016 – YTD*2020)

Table 14: Sunesis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2016 – YTD*2020)

Table 15: Sunesis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2016 – YTD*2020)

Table 16: Sunesis Pharmaceuticals, Inc.: News and Events Summary

Table 17: Sunesis Pharmaceuticals, Inc.: Corporate Governance

Table 18: Sunesis Pharmaceuticals, Inc.: Financial Performance

Table 19: Sunesis Pharmaceuticals, Inc.: Regulatory and Legal Events

Table 20: Sunesis Pharmaceuticals, Inc.: Research & Development

List of Figures

List of Figures

Figure 1: Sunesis Pharmaceuticals, Inc.: Deal Activity by Deal Type – Volume (TTM*)

Figure 2: Sunesis Pharmaceuticals, Inc.: Deal Activity by Deal Type – Volume (2016 – YTD*2020)

Figure 3: Sunesis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2016 – YTD*2020)

Figure 4: Sunesis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2016 – YTD*2020)

Figure 5: Sunesis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2016 – YTD*2020)

Figure 6: Sunesis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2016 – YTD*2020)

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports